🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this phase 0 proof-of concept study is to measure the therapeut...
Status
Unknown
Location
Division of Nuclear Medicine, University Hospital Basel
Start Date
2023-03-28
Trial ID
NCT05359146
Treatments Being Tested
The purpose of the study is to determine the appropriate pediatric dosage a...
Status
Recruiting
Location
UCSF Benioff Children's Hospital
Start Date
2025-09-26
Trial ID
NCT06441331
Treatments Being Tested
The rationale behind the purpose of this study lays on: * the evidence tha...
Status
Unknown
Location
University Hospital of Ferrara
Start Date
2018-07-02
Trial ID
NCT04790708
The purpose of the study is to evaluate efficacy and safety of Peptide Rece...
Status
Active Not Recruiting
Location
Banner Health d.b.a. Banner MD Anderson Cancer Center
Start Date
2017-02-02
Trial ID
NCT03049189
Treatments Being Tested
This phase II trial studies how well lutathera works in treating patients w...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2020-04-14
Trial ID
NCT04082520
This phase II trial investigates how well 177Lu-DOTATATE works in treating ...
Status
Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2026-06-30
Trial ID
NCT04529044
Determine the safety and effectiveness of Lu-177 DOTATOC in adult subjects ...
Status
Withdrawn
Location
Excel Diagnostics and Nuclear Oncology Center
Start Date
2020-03-04
Trial ID
NCT04276597
Treatments Being Tested
Meningiomas are known to be the most frequent intracranial neoplasms and ac...
Status
Recruiting
Location
University Hospital Basel, Department of Neurosurgery
Start Date
2021-04-21
Trial ID
NCT04997317
There are several ways of personalizing PRRT (peptide receptor radionuclide...
Status
Recruiting
Location
Sahlgrenska University Hospital, Dept. of Oncology
Start Date
2022-11-01
Trial ID
NCT05387603
Treatments Being Tested
Peptide receptor radionuclide therapy (PRRT) may be recommended in G1- G2 G...
Status
Recruiting
Location
AUSL Romagna - Ospedale "M. Bufalini"
Start Date
2023-09-13
Trial ID
NCT06045260
Treatments Being Tested